UNION therapeutics announces enrollment of the first patient in ADESOS Phase 2b study of orismilast MR tablet in patients with atopic dermatitis ...Middle East

ADESOS is a Phase 2b dose-finding study of orismilast modified release (MR) tablet in moderate to severe atopic dermatitis (AD) with the purpose of identifying the appropriate dose-regimen for Phase 3 studies AD is the most common chronic inflammatory skin disease in the developed world...

Read More Details
Finally We wish PressBee provided you with enough information of ( UNION therapeutics announces enrollment of the first patient in ADESOS Phase 2b study of orismilast MR tablet in patients with atopic dermatitis )

Also on site :

• '80s Sitcom Star, 48, Stuns Fans with Makeup-Free Beach Pic: 'Jaw Just Dropped'
• Zillow CEO Jeremy Wacksman is using AI to transform the real estate industry—for buyers, sellers, and agents
• Sam Altman scoffs at Mark Zuckerberg’s AI recruitment drive and says Meta hasn’t even got their ‘top people’